Aminotransferase-catalyzed asymmetric synthesis of benazepril intermediate
- First Online:
- 160 Downloads
Benazepril is a medication used to treat hypertension, congestive heart failure and chronic renal failures. A benazepril intermediate was synthesized through asymmetric synthesis using aromatic aminotransferase from Enterobacter sp. BK2K-1 (AroATEs). Sodium 4-methoxy-4-(2-nitrophenyl)-2-oxobutanoate (1) and (E)-4-(2-nitrophenyl)-2-oxobut-3-enoic acid (2) were tested as amino acceptors for the transamination by AroATEs. The AroATEs showed higher activity towards 1, which could be explained using a docking simulation. Both the substrate and product inhibitions for the reaction of 1 as an amino acceptor and l-glutamate as an amino donor were examined. The product inhibition by α-ketoglutarate was able to be solved by the removal of the product using the glutamate dehydrogenase (GDH) and formate dehydrogenase (FDH) coupling system. Using 50 mM of 1, above 99% conversion (> 99% ee) was achieved using the AroATEs, with the GDH and FDH combined system.
Keywordsaminotransferase benazepril product inhibition reaction coupling docking simulation
- 3.Bornscheuer, U. T. (2005) Trends and challenges in enzyme technology. Adv. Biochem. Eng. Biotechnol. 100: 181–203.Google Scholar
- 11.Cho, B. K., H. Y. Park, J. H. Seo, K. Kinnera, B. S. Lee, and B. G. Kim (2004) Enzymatic resolution for the preparation of enantiomerically enriched D-beta-heterocyclic alanine derivatives using Escherichia coli aromatic L-amino acid transaminase. Biotechnol. Bioeng. 88: 512–519.CrossRefGoogle Scholar
- 24.Kragl, U., D. Vasic-Racki, and C. Wandrey (1996) Continuous production of L-tert-leucine in series of two enzyme membrane reactors. Modelling and computer simulation. Bioproc. Eng. 14: 291–297.Google Scholar